Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases

E Beurel, SF Grieco, RS Jope - Pharmacology & therapeutics, 2015 - Elsevier
Abstract Glycogen synthase kinase-3 (GSK3) may be the busiest kinase in most cells, with
over 100 known substrates to deal with. How does GSK3 maintain control to selectively …

[HTML][HTML] GSK-3 as potential target for therapeutic intervention in cancer

JA McCubrey, LS Steelman, FE Bertrand, NM Davis… - Oncotarget, 2014 - ncbi.nlm.nih.gov
The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified and
studied in the regulation of glycogen synthesis. GSK-3 functions in a wide range of cellular …

[HTML][HTML] Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

NM Davis, M Sokolosky, K Stadelman, SL Abrams… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Abstract The EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway plays prominent roles in
malignant transformation, prevention of apoptosis, drug resistance and metastasis. The …

Glycogen synthase kinase 3: more than a namesake

GV Rayasam, VK Tulasi, R Sodhi… - British journal of …, 2009 - Wiley Online Library
Glycogen synthase kinase 3 (GSK3), a constitutively acting multi‐functional serine threonine
kinase is involved in diverse physiological pathways ranging from metabolism, cell cycle …

Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy

J Luo - Cancer letters, 2009 - Elsevier
Glycogen synthase kinase 3β (GSK3β), a multifunctional serine/threonine kinase found in all
eukaryotes, had been initially identified as a key regulator of insulin-dependent glycogen …

[HTML][HTML] Glycogen synthase kinase-3 (GSK-3)-targeted therapy and imaging

MK Pandey, TR DeGrado - Theranostics, 2016 - ncbi.nlm.nih.gov
Abstract Glycogen synthase kinase-3 (GSK-3) is associated with various key biological
processes, including glucose regulation, apoptosis, protein synthesis, cell signaling, cellular …

Glycogen synthase kinase 3 beta: can it be a target for oral cancer

R Mishra - Molecular cancer, 2010 - Springer
Despite progress in treatment approaches for oral cancer, there has been only modest
improvement in patient outcomes in the past three decades. The frequent treatment failure is …

Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer

S Nagini, J Sophia, R Mishra - Seminars in cancer biology, 2019 - Elsevier
Abstract Glycogen synthase kinase-3 (GSK-3), a serine/threonine kinase is an archetypal
multifunctional moonlighting protein involved in diverse cellular processes including …

Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation

S Lim, KR Smith, STS Lim, R Tian, J Lu, M Tan - Cell & bioscience, 2016 - Springer
The mitochondria are double membrane-bound organelles found in most eukaryotic cells.
They generate most of the cell's energy supply of adenosine triphosphate (ATP). Protein …

Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses

I Sahin, A Eturi, A De Souza, S Pamarthy… - Cancer biology & …, 2019 - Taylor & Francis
As a kinase at the crossroads of numerous metabolic and cell growth signaling pathways,
glycogen synthase kinase-3 beta (GSK-3β) is a highly desirable therapeutic target in cancer …